-
OSF HealthCare Implements New Digital Solutions to Help Consumers Find the Right Care Online
Oct 1, 2020, 10:54 AM by Michael CroftBOSTON, MA, UNITED STATES - Oct 1, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that OSF HealthCare, a not-for-profit Catholic health system based in Illinois, is now connecting consumers with care through Kyruus ProviderMatch® for ConsumersFull story -
AARDEX Group partners with BIOCORP to extend digital solutions for precision medication adherence
Oct 1, 2020, 10:00 AM by Michael CroftISSOIRE, FRANCE - Oct 1, 2020 - Belgium-based AARDEX Group, the world leader in medication adherence solutions, today announced a strategic partnership with BIOCORP, a French company specialized in the design, development and manufacture of innovative medical devicesFull story -
GA4GH Announces Strategic Roadmap, Connection Demos
Sep 30, 2020, 17:15 PM by Michael CroftBio-IT World The Global Alliance for Genomics and Health (GA4GH) has announced the release of its 2020-2021 Strategic Roadmap yesterday at the virtual GA4GH 8th Plenary Meeting, and released three 2020 Connection Demos to illustrate the deployments of GA4GH standards.Full story -
Bio-IT World Expo New Product Showcase Voting Opens
Sep 30, 2020, 16:00 PM by Michael CroftFull storyBio-IT World | Voting is open now for the 2020 Bio-IT World Best of Show Awards. This annual new product award highlights entries that are innovative, progressive, and will demonstrably improve the bio-IT industry. This year's finalists include new products from BC Platforms, Benchling, ConvergeHEALTH, Flywheel, Genedata, Genestack, Globus, GNS Healthcare, Igneous, Illumina, Kanda Software, LabTwin, Lifebit, Linguamatics, NetApp, PercayAI, PetaGene, QIAGEN, Qumulo, Rescale, Riffyn, Synthace, Univa, and Zifo Technologies.
-
Sterling Pharma Solutions acquires API facility in the US
Sep 30, 2020, 12:39 PM by Michael CroftGERMANTOWN, WI, US - Sep 30, 2020 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced its acquisition of Alcamis Germantown, Wisconsin facility in the USFull story -
Synthetic Biology start up NanoSyrinx secures capital to develop its fully customisable platform for intra-cellular engineering
Sep 30, 2020, 05:08 AM by Michael CroftCOVENTRY, UNITED KINGDOM - Sep 30, 2020 - NanoSyrinx, an emerging biotechnology company developing new therapeutic modalities for Cell & Gene editing, announced the closing of a Pre-Seed financing led by M Ventures (Amsterdam, The Netherlands), the corporate venture capital arm of MerckFull story -
3 Game-changing Cybersecurity Practices Pharmaceuticals Should Take into Consideration
Sep 29, 2020, 13:55 PM by Michael CroftBio-IT World Pharmaceutical breakthroughs and medical research comprise an immeasurably important chunk of the global healthcare industry, warranting an equally robust cybersecurity infrastructure. The healthcare industry is no stranger to the devices of cybercriminals who target hospitals, clinics, research institutions, and pharmaceutical companies in search of highly expensive personal health information to be sold on the darknet.Full story -
Standigm and SK holdings C&C Release an AI-Based Target Identification Platform, iCLUE&ASK™, to Accelerate Drug Discovery Process
Sep 29, 2020, 09:25 AM by Michael CroftSEOUL, SOUTH KOREA - Sep 29, 2020 - Standigm Inc. (Standigm), an artificial intelligence (AI)-based drug discovery company, and SK holdings C&C, CoFull story -
More ‘Omics for SARS-CoV-2, Insights into the Spike Protein, Crowdsourcing Questions: COVID-19 Updates
Sep 25, 2020, 11:05 AM by Michael CroftBio-IT World | A Canadian team shares a new mechanism of action for remdesivir, data science groups have computed consensomes (gene expression in the virus) and interactomes (potential molecular mechanisms of pathogenesis) and cryoEM images the spike protein. Plus, NIH funding for new vaccines and the Reliable Response Data Discovery consortium takes COVID-19 patient data questions.Full story -
Ecological Modeling Of Gut Microbiome Points To Probiotic Cures
Sep 24, 2020, 14:25 PM by Michael CroftBio-IT World Fecal microbiota transplantation (FMT), the idea of using fecal material from a healthy person to treat others who are sick, has been proposed for challenging conditions ranging from inflammatory bowel disease to autism and obesity. But to date, robust evidence from randomized clinical trials exists only for the use of FMT to treat recurrent C. difficile infection.Full story -
The Role of Data Management in Advancing Biology
Sep 22, 2020, 03:05 AM by Michael CroftFull storyBio-IT World Kjiersten Fagnan had a plan: she would be an engineer, work for a company, and write software all day. But biology is intriguing and now Fagnan is the Chief Informatics Officer at the Joint Genome Institute. She recently spoke with Stan Gloss, founding partner at the BioTeam, about the community challenges around creating and sharing more useful data, and how “human engineering” can help advance biology.
-
Sticky Webs, A Tiny Molecular Weapon, Obesity Paradox N/A: COVID-19 Updates
Sep 18, 2020, 01:20 AM by Michael CroftBio-IT World New drug targets, reconstructing viral spread and lineage, monitoring mutations, reasons to focus on T-cell responses, DNA webs as culprits of tissue damage, a very tiny neutralizing agent, explaining paradoxical risk in people with obesity and diabetes, and the value of heparan. Plus, a new vaccine candidate heading to human trials, coronaviruses are being profiled, and a deep dive on how SARS-CoV-2 weakens the immune system.Full story -
Jumpcode Genomics Exits Stealth Mode, Unveils Technology that Addresses the ‘Needle in the Haystack’ Problem of Molecular Biology
Sep 17, 2020, 16:20 PM by Michael CroftCARLSBAD, CA, UNITED STATES - Sep 17, 2020 - Jumpcode Genomics – a genome technology company founded by industry veterans in 2016 focused on improving the understanding of human disease – today exited stealth mode and announced the commercial launch of its CRISPRclean technologyFull story -
Targeted Protein Degradation: Why Just Inhibit What Can Be Destroyed?
Sep 17, 2020, 13:45 PM by Michael CroftBio-IT World Disease treatment through targeted protein degradation takes a range of approaches: from small molecules similar to thalidomide that act as “molecular glue” degraders to more advanced “beyond rule of 5” proteolysis-targeting chimeras (PROTACs) with bifunctional moieties that encourage protein interaction with its E3 ubiquitin ligase.Full story -
Romain Madelaine, Ph.D., Joins MDI Biological Laboratory Faculty
Sep 17, 2020, 09:49 AM by Michael CroftBAR HARBOR, ME, UNITED STATES - Sep 17, 2020 - The MDI Biological Laboratory has announced that Romain Madelaine, Ph.D., has been appointed to the faculty as an assistant professorFull story -
Huntington Study Group Announces a Partnership with Prilenia Therapeutics to Conduct a Global Phase 3 Clinical Study of Pridopidine in Huntington’s Disease
Sep 17, 2020, 07:12 AM by Michael CroftROCHESTER, NY, UNITED STATES - Sep 17, 2020 - The Huntington Study Group (HSG), a world leader in clinical research for Huntingtons Disease (HD), announces a partnership with Prilenia Therapeutics, a clinical stage biotech company led by Michael RFull story -
ZEISS enhances efficiency in multi-scale and multi-modal workflows
Sep 16, 2020, 15:45 PM by Michael CroftJENA, GERMANY - Sep 2, 2020 - Materials and Life Science researchers can now experience faster accessibility of deeper regions of interest when investigating samples in 3DFull story -
2bPrecise Wins Industry Innovation Award
Sep 16, 2020, 11:51 AM by Michael CroftRALEIGH, NC, UNITED STATES - Sep 16, 2020 - Fierce Healthcare released its annual Fierce Innovation Report this week, naming 2bPrecise the industrys top clinical information management solutionFull story -
Imvax Appoints Wendy DiCicco as New Board Member
Sep 16, 2020, 08:56 AM by Michael CroftPHILADELPHIA, PA - Sep 16, 2020 - Imvax, Inc., an emerging oncology leader that is revolutionizing immunotherapy for patients with malignant glioblastomas (GBM) and other solid tumors with significant unmet medical needs, today announced the appointment of Wendy DiCicco to its board of directorsFull story -
Continuous Software Validation Critical for Balancing Digital Transformation and Compliance
Sep 16, 2020, 01:20 AM by Michael CroftBio-IT World The adoption of cloud technology in the life science industry has become increasingly pervasive as firms move forward with digital transformation initiatives aimed at creating operational efficiencies and delivering the next wave of biomedical innovations. As a result, cloud vendors are playing a more important role than ever before, especially for life sciences companies that produce FDA-regulated products.Full story